In vivo generation of lymphokine-activated killer cells by sensitization with interleukin 2-producing syngeneic T-lymphoma cells
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 112 (1) , 220-225
- https://doi.org/10.1016/0008-8749(88)90290-0
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Administration of slowly released recombinant interleukin 2 Augmentation of the efficacy of adoptive immunotherapy with lymphokine-activated killer (LAK) cellsJournal of Immunological Methods, 1986
- Generation of lymphokine-activated killer (LAK) cells from tumor-infiltrating lymphocytesCellular Immunology, 1986
- Use of millipore diffusion chambers to assay in vivo IL-2 activityJournal of Immunological Methods, 1985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu miceNature, 1980
- Long term culture of tumour-specific cytotoxic T cellsNature, 1977
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976
- Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificityInternational Journal of Cancer, 1975
- Cell-Mediated Cytotoxicity, Allograft Rejection, and Tumor ImmunityPublished by Elsevier ,1974